Chest[journal] 检索结果

5221. A Woman With Recent Stroke Presenting With Respiratory Failure and Shock.

作者: Hannah R Ferenchick.;Abigail T Chua.;Anthony J Carlese.;Ariel L Shiloh.
来源: Chest. 2018年153卷5期e101-e103页

5222. Correction to Figures in: Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.

来源: Chest. 2018年153卷5期1287页

5223. Weekday and Survival After Pulmonary Resections for Lung Cancer: A Swedish Nationwide Cohort Study.

作者: Veronica Jackson.;Mamdoh Al-Ameri.;Ulrik Sartipy.
来源: Chest. 2018年153卷5期1284-1286页

5224. Asthma Breathomics and Biomedium Consideration.

作者: Adam M Peel.;Yoon K Loke.;Andrew M Wilson.
来源: Chest. 2018年153卷5期1283页

5225. Response.

作者: Rachel S Kelly.;Jessica Lasky-Su.
来源: Chest. 2018年153卷5期1283-1284页

5226. Response.

作者: Jennifer K Quint.
来源: Chest. 2018年153卷5期1282-1283页

5227. Pulmonary Rehabilitation, Exercise, and Exacerbations of COPD: Known Clinical Efficacy and the Unknown Mechanisms.

作者: Alex R Jenkins.;Neil S Holden.;Arwel W Jones.
来源: Chest. 2018年153卷5期1281-1282页

5228. Response.

作者: Jurjen van der Schans.;Eelko Hak.;Pieter J Hoekstra.;Tjalling W de Vries.
来源: Chest. 2018年153卷5期1280-1281页

5229. Attention-Deficit/Hyperactivity Disorder and Comorbid Asthma.

作者: Keith Fluegge.;Kyle Fluegge.
来源: Chest. 2018年153卷5期1279-1280页

5230. Response.

作者: Steven Q Simpson.
来源: Chest. 2018年153卷5期1278-1279页

5231. New Organ Failure as an Alternative Endpoint to Develop Diagnostic Criteria for Sepsis.

作者: Jesus F Bermejo-Martin.;Raquel Almansa.;Juan Carlos Yebenes.
来源: Chest. 2018年153卷5期1278页

5232. Giants in Chest Medicine: Professor Emerita A. Sonia Buist, MBChB, MD.

作者: Jerry A Krishnan.
来源: Chest. 2018年153卷5期1091-1092页

5233. Building the Future of Trial Design in PAH on Solid Ground.

作者: Rogerio Souza.;Juliana C Ferreira.
来源: Chest. 2018年153卷5期1089-1090页

5234. Time to Understand the Infrequency of the Frequent Exacerbator Phenotype in COPD.

作者: Wassim W Labaki.;Fernando J Martinez.
来源: Chest. 2018年153卷5期1087-1088页

5235. Is Big Tobacco Still Trying to Deceive the Public? This Is No Time to Rest on Our Laurels.

作者: Donald Robert McCaffree.;Neeraj R Desai.
来源: Chest. 2018年153卷5期1085-1086页

5236. Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension.

作者: Yu Taniguchi.;Philippe Brenot.;Xavier Jais.;Carlos Garcia.;Jason Weatherald.;Olivier Planche.;Elie Fadel.;Marc Humbert.;Gérald Simonneau.
来源: Chest. 2018年154卷3期521-531页

Poor subpleural perfusion (PSP) in the capillary phase of pulmonary angiography predicts worse outcomes following pulmonary endarterectomy in operable chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) has emerged as a treatment for nonoperable CTEPH. The goal of the present article was to assess the association between PSP and BPA failure.

5237. The Evolutional History of Electromagnetic Navigation Bronchoscopy: State of the Art.

作者: Atul C Mehta.;Kristin L Hood.;Yehuda Schwarz.;Stephen B Solomon.
来源: Chest. 2018年154卷4期935-947页

Electromagnetic navigation bronchoscopy (ENB) has come a long way from the early roots of electromagnetic theory. Current ENB devices have the potential to change the way lung cancer is detected and treated. This paper provides an overview of the history, current state, and future of ENB.

5238. Cardiac Cath Labs: Their Origins and Their Future.

作者: James E Dalen.;Joseph S Alpert.
来源: Chest. 2018年154卷3期487-490页

More than 1 million diagnostic cardiac catheterizations (excluding percutaneous coronary intervention-only procedures) are performed each year in the nearly 2,000 cardiac catheterization laboratories in the United States.1.

5239. Withdrawn: Combination of NSAID and Antitussives in Treatment of URTI Related Cough: An Observational Study.